My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2919

    1.

    Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Diabetes Care. 2004 Jun;27(6):1439-46.PMID: 15161801 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.

    Osei K, Gaillard T, Schuster DP.

    Diabetes Care. 1997 Mar;20(3):396-404.PMID: 9051394 [PubMed - indexed for MEDLINE]Related articles

    4.

    History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes.

    Osei K, Gaillard TR, Schuster DP.

    Diabetes Care. 1998 Aug;21(8):1250-7.PMID: 9702429 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2004 Apr;53(4):414-22.PMID: 15045685 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

    Osei K, Gaillard T, Schuster D.

    Metabolism. 2007 Jan;56(1):24-9.PMID: 17161222 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

    Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group.

    Diabetes. 2002 Jul;51(7):2170-8.PMID: 12086947 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients]

    Han XY, Ji LN, Zhou XH.

    Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1777-80. Chinese. PMID: 15631772 [PubMed - indexed for MEDLINE]Related articles

    10.

    Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

    Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE.

    Diabetes Care. 2007 Mar;30(3):677-82.PMID: 17327340 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    12.

    Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

    Motala AA, Omar MA, Gouws E.

    Diabetes Care. 1997 Jul;20(7):1101-7.PMID: 9203444 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.

    Osei K, Gaillard T, Kaplow J, Bullock M, Schuster D.

    Metabolism. 2004 Dec;53(12):1552-7.PMID: 15562399 [PubMed - indexed for MEDLINE]Related articles

    14.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.

    Shalitin S, Abrahami M, Lilos P, Phillip M.

    Int J Obes (Lond). 2005 Jun;29(6):571-8.PMID: 15889115 [PubMed - indexed for MEDLINE]Related articles

    16.

    Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians.

    Osei K, Cottrell DA, Adenuwon CA, Ezenwaka EC, Akanji AO, O'Dorisio TM.

    Diabetes Care. 1993 Oct;16(10):1367-75.PMID: 8269795 [PubMed - indexed for MEDLINE]Related articles

    17.

    Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.

    Osei K, Schuster DP.

    Am J Med Sci. 1996 Mar;311(3):113-21.PMID: 8615385 [PubMed - indexed for MEDLINE]Related articles

    18.

    Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

    Viswanathan V, Clementina M, Nair BM, Satyavani K.

    J Assoc Physicians India. 2007 Dec;55:833-7.PMID: 18405128 [PubMed - indexed for MEDLINE]Related articles

    19.

    Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity.

    Tripathy D, Almgren P, Tuomi T, Groop L.

    Diabetes Care. 2004 Sep;27(9):2204-10.PMID: 15333485 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.

    Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L.

    Diabetologia. 2000 Dec;43(12):1476-83.PMID: 11151756 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity